PWPS
ADMA icon

Pinnacle Wealth Planning Services’s ADMA Biologics ADMA Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Sell
4,299
-137
-3% -$1.25K ﹤0.01% 1499
2026
Q1 		$40K Buy
4,436
+1,398
+46% +$22.1K ﹤0.01% 1326
2025
Q4 		$55.4K Buy
+3,038
New +$51.2K 0.01% 1126

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Pinnacle Wealth Planning Services's ADMA Position: Q2 2026 in Review

Pinnacle Wealth Planning Services reduced its ADMA Biologics (ADMA) stake by 3.1% in Q2 2026, selling an estimated $1.25K and leaving 4,299 shares worth $36K. The position accounts for ﹤0.01% of the portfolio, ranked #1499.

Pinnacle Wealth Planning Services first reported a position in ADMA in Q4 2025 and has held it in 3 quarters since. The position peaked at $55.4K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Pinnacle Wealth Planning Services held 4,299 shares of ADMA Biologics worth $36K as of Q2 2026.
  • Pinnacle Wealth Planning Services sold 137 ADMA Biologics shares in Q2 2026, an estimated $1.25K.
  • ADMA Biologics made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1499 holding.
  • Pinnacle Wealth Planning Services first reported a position in ADMA Biologics in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Wealth Planning Services's ADMA Biologics position peaked at $55.4K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.